ArticleFrontiers in medicine2021

Heterologous Hyperimmune Polyclonal Antibodies Against SARS-CoV-2: A Broad Coverage, Affordable, and Scalable Potential Immunotherapy for COVID-19.

Alberto Alape-Girón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.